Yüklüyor......
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
BRCA and poly-ADP ribose polymerase (PARP) regulate pathways of DNA repair. Due to the accumulation of mutations introduced by error-prone DNA repair, breast and ovarian cancers develop in the setting of BRCA deficiency. A series of recent clinical trials has tested the use of PARP inhibition as a t...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Faculty of 1000 Ltd
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948351/ https://ncbi.nlm.nih.gov/pubmed/20948822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/B2-10 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|